Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Dr Catherine Strader joins Acorda Therapeutics’ board

She brings experience from Merck & Co and Synergy Partners R&D Solutions

Making sense of Nutraceuticals in China

Published in eyeforpharma February 2017 by Marc Yates

Inizio

Research Partnership has been ranked in the Pharma Times Pharma Fast 50

Industry Magazine Pharma Times has partnered with Catalyst Corporate Finance to publish a detailed analysis of the 50 fastest growing private, independently owned pharma companies in the UK and Research...

Inizio

Women’s health in emerging markets

Why can understanding and improving women’s health in emerging markets be challenging? What strategies can global pharma develop to support women and overcome these challenges? Associate Director Rachel Howard and...

Inizio

Research Partnership has published a new Living with Lupus (SLE) market report for 2017

SLE is a progressive and debilitating disease which affects 5 million people worldwide.

Inizio

Porterhouse Medical – where people make the difference

Porterhouse Medical, a global medical and scientific communications agency, explains in their new corporate video why they focus on their people and the company's values.

Porterhouse Medical Group

National Institute for Health and Care Excellence NICE logo

Amicus gets NICE green light for Fabry drug

Oral therapy alternative Galafold approved for routine NHS use

- PMLiVE

FDA verdict on Pfizer’s breakthrough leukaemia drug due in August

Phase III trials results saw complete remission in 81% of patients in the treatment group

- PMLiVE

Lighting the way

How the UK’s Accelerated Access Review aims to guide medical innovations to their destination

- PMLiVE

PM Society appoints new chairman

Craig Bradley succeeds Rachel Farrow and Carwyn Jones

- PMLiVE

Adelphi Research UK promotes Claire Nelson and Steve Loasby

Become research director and research manager, respectively

AstraZeneca AZ

Generic version of AZ’s Iressa launched in China

Qilu Pharma’s Yiruike licensed as first-line NSCLC treatment

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links